(Circulation. 2000;102:2898.)
© 2000 American Heart Association, Inc.
Current Perspective |
From the Division of Clinical Pharmacology, DuPont Pharmaceuticals, Wilmington, Del (R.M.-G., R.F.-V.); Centro Ricerche Cardiovascolari, CNR, Medicina Interna II, Ospedale "L. Sacco," Università di Milano, Italy (R.F.); and Clinic Bavaria Kreischa, Department of Diabetes and Endocrinology, Keischa, Germany (J.T.).
Correspondence and reprint requests to Dr Rogelio Mosqueda-Garcia, Dupont Pharmaceuticals Co, Chestnut Run Plaza, WR 2081, 974 Centre Road, Wilmington, DE 19805. E-mail Agustin.r.Mosqueda{at}Dupontpharma.com
Key Words: baroreceptors catecholamines nervous system, autonomic syncope microneurography
| Introduction |
|---|
|
|
|---|
30% of affected patients will experience
recurrent episodes.1
Neurally mediated syncope (NMS) is a common type of syncope (Figure 1
); clinical descriptions of it have been
present in the medical literature for >100 years. Despite its
prevalence, significant gaps in our understanding of its
pathophysiology and treatment remain. The purpose of this review is to
critically evaluate proposed theories that attempt to explain the
pathophysiological mechanisms of NMS.
|
| Definition |
|---|
|
|
|---|
| Classification |
|---|
|
|
|---|
Postural NMS typically develops while the subject is standing or walking, and it is much more frequent than the central and situational types. As determined using a referral population evaluated at the Syncope Unit at Vanderbilt Hospital, 94% of NMS cases fall into this category (unpublished data, R. Mosqueda-Garcia). Central NMS remains poorly characterized in humans. In susceptible individuals, emotional stimulation can activate ill-defined areas within the central nervous system that, in turn, trigger sympathetic inhibition and parasympathetic activation. Situational NMS relates to the specific stimulation of different and seemingly unrelated visceral, sensory-proprioceptive, or specialized afferents that result in hypotension and syncope. Examples include the types of syncope evoked by the hypersensitivity of carotid baroreceptors, rapid bladder distension, and gastrointestinal tract distention.
This review will discuss the pathophysiological aspects of postural NMS, without exploring the pathophysiology of the other types.
| Pathophysiology |
|---|
|
|
|---|
|
Pathophysiological Mechanisms in Postural
NMS
Often, NMS develops after the subject experiences changes in
gravitational forces.6 One study suggested that an
abnormality in the peripheral veins could result in
exaggerated orthostatic pooling while
standing.7 Supporting this is the observation of greater
increments in calf venous volume with less variability during
orthostatic stress8 in subjects prone to
syncope. Others have shown decreased skeletal muscle tone in the lower
extremities during upright tilt9 or a failure of reflex
venoconstriction during exercise.10 In contrast, another
study documented venoconstriction in the forearm or hand veins of
patients with NMS during orthostatic stress.11
Also opposing the idea of exaggerated venous pooling in NMS patients
are studies documenting similar decreases in central venous pressure
during head-up tilt when compared with controls.11 12
After the initiating events of syncope, a complex hemodynamic response develops, resulting in marked hypotension, variable bradycardia, and loss of consciousness. Several theories have been advanced to account for these hemodynamic events. They are critically evaluated below.
| The Ventricular Theory |
|---|
|
|
|---|
|
The ventricular theory was first proposed by Sharpey-Schafer,14 and it gained wide acceptance because it seemed to explain some clinical pathophysiological observations (ie, exertional syncope in aortic stenosis).13 In addition, this theory seemed to provide a rational basis for the combination of isoproterenol and tilt (in the diagnosis) and the use of ß-adrenergic blockers (in the treatment) for NMS.15 Significant experimental observations, however, are not explained by this theory, and they challenge the concept of ventricular mechanoreceptors as responsible for the universal development of NMS.
Activation of Ventricular Mechanoreceptors
Recordings of Afferent Traffic
Studies by Oberg and Thoren16 seemed to provide an
anatomical substrate explaining the development of NMS. These authors
recorded increments in afferent vagal activity during the
bradycardic effect evoked by vena cava occlusion. Detailed
analyses of their results, however, indicate that only a
minority of the ventricular afferents (
20%) excited
after vena cava occlusion also responded with excitation during the
hemorrhagic event. Furthermore, they acknowledged that the vagal
filaments recorded in their experiments were not randomly sampled,
which lead to an overrepresentation of studied
ventricular afferents.16 Overall, it was not
clear if a "real" increase in ventricular afferent
activity was present with decreases in ventricular
load.
Sympathetic Withdrawal in Denervated Hearts
A direct challenge to the relevance of ventricular
afferents came from studies demonstrating that the inhibition of
sympathetic nerve activity evoked by hemorrhage remained
intact, even with total denervation of the heart.17 In
humans, NMS can be evoked in patients with heart
transplants,18 a circumstance that is independent of
autonomic reinnervation of the ventricle. Although it may be proposed
that receptors in other cardiovascular regions may be
excited by hypovolemia and trigger NMS, no experimental evidence of
increased afferent traffic from other thoracic regions is yet
available.
Ventricular Hypovolemia
Echocardiographic Determinations
The concept of circulating hypovolemia resulting from venous
pooling and causing a decrease in filling return to the heart is one
main postulate of the ventricular theory. Earlier reports
found evidence of significant decreases in left ventricular
dimensions.19 20 However, many of these studies were
performed either in subjects without spontaneous NMS or after high
doses of isoproterenol. More recently, others have demonstrated no
significant decreases in cardiac chamber size or volume during tilt, at
the time of presyncope, or during syncope in patients with
well-characterized NMS.21 Similarly, others were unable to
record significant changes in left ventricular
end-diastolic or end-systolic
dimensions.22
Increased Sympathetic Tone
Plasma Norepinephrine Determinations
Another important premise of the ventricular theory is
the presence of increased sympathetic tone. Attempts to evaluate
sympathetic function with plasma norepinephrine in patients
with NMS have produced contradictory results. Although some studies
have reported moderate elevations,20 others have found
normal23 or even decreased6 12 24 25 plasma
norepinephrine levels preceding syncope. One detailed study
of the sympathetic responses during tilt12 documented that
when compared with controls, a blunted maximal increase in
norepinephrine levels was observed in NMS patients (Figure 4
).
|
In part, all these dissimilar results6 12 20 23 24 25 may be explained by methodological limitations. Changes in synaptic norepinephrine only subsequently result in changes in norepinephrine levels in the peripheral circulation. This makes the time of blood sampling a source of significant variability. Likewise, changes in the rate of norepinephrine clearance or in spillover to the general circulation,26 which are likely to develop during hypotension, may also account for the variable concentrations of this neurotransmitter. Furthermore, the interpretation of plasma norepinephrine samples is meaningless without the proper consideration of associated hemodynamic factors.27 While standing, 2- to 3-fold increases in plasma norepinephrine are normal.27 However, similar increments in norepinephrine will be inappropriate in subjects experiencing hypotension.
Norepinephrine Spillover Determinations
Using total and cardiac norepinephrine spillover,
some investigators have recorded decreases in
norepinephrine release during syncope26 or
blunted increases in the response to orthostatic stress in
patients who subsequently developed syncope.25 Increases
in sympathetic activity in these studies, however, cannot be completely
excluded because these reports did not obtain temporal determinations
of norepinephrine spillover.
Sympathetic Nerve Traffic Recordings
Microneurography has been used to study sympathetic responses in
NMS because it can continuously assess neural sympathetic traffic.
Initial reports presented only microneurographic tracings from
either healthy volunteers28 29 30 or from one patient not
suffering from postural NMS.31 These reports were
anecdotal and did not account for the reciprocal relationship between
BP and sympathetic outflow. More systematic studies in NMS patients
have now clearly shown that muscle sympathetic nerve activity (MSNA)
does not increase before syncope.12 32 33 In one of these
studies,12 the investigators recorded MSNA in subjects
who consistently experienced postural NMS, both spontaneously
and during tilt. The microneurographic responses of NMS patients were
characterized by blunted MSNA increases during tilt followed by a
progressive reduction until total disappearance a few seconds before
syncope (Figure 5
). In clear contrast,
normotensive controls exhibited significant increases in MSNA in
response to orthostatic stress that were well maintained
for the entire period of tilt.12 Interestingly, in
subjects who only experienced syncope while undergoing tilt
(false-positive), the microneurographic response was apparently
exaggerated, with a more sudden withdrawal before syncope (Figure 6
).12 One important
conclusion from this study was the concept that the sympathetic
responses to orthostatic stress are entirely different in
patients with spontaneous NMS and in subjects who experience syncope
only during tilt. This indicates that many observations obtained from
so called vasovagal episodes in healthy control subjects cannot be
readily extrapolated to patients with recurrent NMS.
|
|
Failure to record increases in MSNA preceding syncope has also been reported by others, either during tilt34 or during lower-body negative pressure32 (LBNP). Nevertheless, it can be argued that recordings of MSNA may not reflect the noradrenergic changes evoked in other relevant regions (ie, heart). However, it is important to note that at least one study documented decreases in the total, cardiac, and renal norepinephrine spillover of subjects experiencing NMS,26 which agrees with the microneurographic recordings discussed above. In addition, others have shown both a progressive decrease in subcutaneous blood flow, consistent with progressive sympathetic withdrawal before the onset of syncope,35 and a reduced cardiac sympathetic tone in NMS when evaluated with spectral analysis of heart rate variability.36
Spectral Analysis of Heart Rate Variability
During tilt, NMS patients exhibit increased vagal cardiac
activity,36 37 with variable responses in cardiac
sympathetic function. While some investigators have found that cardiac
sympathetic tone increases before syncope,38 others have
found the opposite36 or even evidence for
both37 (increase or decrease, depending on the individual
subject). Currently, it is not clear whether differences in methodology
and/or the selection of patients may account for these
discrepancies.
Manipulation of Sympathetic Tone
An attractive way to test the ventricular theory is to
investigate whether sympathetic stimulation is an essential requirement
for the development of NMS. The rationale behind this notion is that an
increase in sympathetic outflow should worsen NMS, whereas a reduction
in sympathetic tone could potentially prevent it. Recently,
Mosqueda-Garcia et al33 demonstrated (contrary to what
would have been expected with the ventricular theory) that
the increase in sympathetic tone evoked by yohimbine enhanced
orthostatic tolerance and prevented syncope in most NMS
patients tested.33 Accordingly, a reduction in sympathetic
tone by clonidine resulted in a worsening of the tilt-induced syncope.
Overall, these results strongly indicate that increased sympathetic
activity is not a prerequisite for the development of NMS, and
alternative mechanisms should be sought to explain this syndrome.
| Baroreflex Dysfunction Theory |
|---|
|
|
|---|
Carotid Baroreceptor Stimulation
Studies in animals have demonstrated that
hemorrhage-induced sympathetic inhibition and hypotension could
be prevented by the deafferentation of carotid
baroreceptors.40 In humans, the stimulation of carotid
baroreceptors resulted in smaller reflex heart rate responses in
patients in whom hypotension was detected during a 20-minute tilt-table
test.41 Another study42 indicated that
individuals with a history of vasovagal reactions displayed greater
baroreflex sensitivity. These 2 studies,41 42 however, did
not use classic additional methods of testing baroreflex function,
which would have complemented their observations.
Cardiopulmonary Baroreceptors
Sneddon and collaborators43 studied baroreflex
function in patients with recurrent NMS and with positive or negative
responses to tilt. Although no differences were seen for
arterial high pressure baroreflexes between tilt-positive
and tilt-negative NMS patients, the increase in forearm vascular
resistance in response to LBNP was greater in the tilt-positive
patients.43 They concluded that some NMS patients have
augmented cardiopulmonary baroreceptor responses.
Interpretations of these results, however, are hampered by the absence
of a negative control group (subjects without a history of syncope and
a negative tilt table test) and by their estimation of baroreflex
responses using only vasopressor stimulation.
In a different study, Jacobs and colleagues25 reported that subjects experiencing syncope during -40 mm Hg of LBNP exhibited an already abnormal response to nonhypotensive negative pressures. This response was characterized by a failure of forearm norepinephrine spillover to increase. Their results are indicative of an abnormal resetting of baroreflex function and/or altered responses of low-pressure baroreceptors.
Integrated Baroreflex Evaluation
Thomson et al44 performed a comprehensive assessment
of baroreflex function in controls and in patients with spontaneous NMS
(reproduced by tilt table examination). In NMS patients,
cardiopulmonary receptor sensitivity was severely impaired, as
indicated by the absence of forearm vasoconstriction or, in some
subjects, by the development of paradoxical forearm vasodilation during
nonhypotensive LBNP. When arterial baroreceptor sensitivity
was investigated, a trend for reduced sensitivity was observed in NMS
patients compared with controls.44
Baroreflex abnormalities in NMS may be better documented by a
definition of the entire sigmoidal baroreflex curve. Mosqueda-Garcia et
al12 investigated baroreflex sensitivity on cardiac vagal
and muscle sympathetic fibers by stepwise infusions of
phenylephrine (linear and saturation parts of the curve)
and sodium nitroprusside (threshold and linear parts). Subjects with
recurrent NMS and positive tilt-table tests had reduced cardiac and
sympathetic baroreflex responses when compared with controls (Figure 7
). Other authors have also found
pronounced reductions in baroreflex sensitivity in NMS patients with
positive tilt reactions when compared with patients with negative tilt
tests (Figure 8
).39 In a
subsequent report, the same authors found evidence of reduced vagal
baroreflex gain during pressure reduction/elevation sequences but
intact function with the pressure elevation/reduction
algorithm.34 They indicated that patients who experienced
NMS during tilt have subnormal vagal baroreflex responses to pressure
changes below baseline but no evidence of vagal and sympathetic
baroreflex malfunction during tilt.34 These later
conclusions contrast somewhat with the observations discussed
above.12 39 Although the reasons for these discrepancies
are not clear, it is important to note that in the later
article,34 the authors performed a different type of
analysis (integrated evaluation over 3 mm Hg pressure
ranges), did not have a "true" control group (all the study
subjects had experienced spontaneous syncope; patients either fainted
[positive] or not [control] during their tilt), and all but 2 of
the presyncopal patients in whom microneurography was obtained required
isoproterenol to induce syncope.
|
|
Some authors have suggested that baroreflex function is preserved but
suddenly suppressed by a depressor reflex originating in the
heart.30 In contrast, one study found significant
spontaneous baroreflex function alterations in NMS patients on
assumption of the upright position.12 This study
demonstrated that when compared with controls, NMS patients have
important reductions in the baroreflex correlation slopes between heart
rate and systolic BP (Figure 9
)
or between MSNA and central venous pressure (Figure 10
) during upright tilt.
|
|
Overall, most of the available articles report some type of baroreflex dysfunction that is thought to result in the inability to sense or compensate for changes in gravitational forces in subjects with NMS. The development of sympathetic withdrawal in NMS, however, may result from the paradoxical activation of baroreceptors.12 Some studies have shown baroreceptor resetting leading to sympathoinhibition during severe hemorrhage.45 In humans, plasma norepinephrine first increases and then decreases during progressive reductions of arterial BP.46 In agreement with the idea of baroreceptor resetting is the observation that the inhibition of MSNA declines during continuous electrical stimulation of the carotid sinus nerve in humans.47 Furthermore, the paradoxical activation of arterial baroreceptors has been documented at very low pressures.48
| Reduced Blood Volume Theory |
|---|
|
|
|---|
| Neurohumoral Theories |
|---|
|
|
|---|
Serotonin
One group has proposed that selective serotonin
reuptake inhibitors are successful agents for the treatment
of NMS.54 These authors have indicated that
serotonin surges may occur in humans before syncope and
that these inhibitors will decrease the sensitivity of
serotonin receptors, with subsequent prevention of
NMS.54
To date, no strong experimental evidence supports the involvement of serotonin in NMS. First, the basic studies showing an elimination of the vasodepressor reflex during hemorrhage used serotonin synthesis blockers or serotonin receptor blockers.55 Similar actions have not been reported with selective serotonin reuptake inhibitors. Second, it may be reasonable to speculate that in susceptible subjects, an initial increase in central serotonin levels would aggravate or increase the frequency of NMS. This has not been reported, despite the extensive use of these agents. Finally, studies in humans using serotonin receptor blockers do not show that syncope induced by tilt is prevented.56 Human studies with different subtypes of serotonin-receptor antagonists demonstrated a decreased tolerance to tilt, an acceleration of the development of hypotension, and a reduction of the sympathetic and adrenomedullary response to hypotension, without preventing syncope.56 Overall, the potential involvement of serotonin is highly speculative and has little experimental support.
Renin, Vasopressin, ß-Endorphin, Endothelin, and Nitric
Oxide
Other diverse humoral agents have been implicated in the
pathogenesis of NMS. Increases in plasma levels of
renin,24 vasopressin,57
ß-endorphin,58 endothelin,59 or nitric
oxide6 have been described before the onset of NMS. In
some instances, however, pretreatment with specific receptor
antagonists (ie, naloxone for ß-endorphin)60
or with a nitric oxide synthase inhibitor61
did not prevent the provocation of syncope or the vasodilation
associated with it. In other cases, the increases in plasma
concentrations of these agents (ie, endothelin, vasopressin, and renin)
have not been confirmed, and no evidence is available regarding the
prevention of syncope with selective antagonists (ie,
vasopressin and endothelin).
| Active Vasodilation Theory |
|---|
|
|
|---|
More recently, Dietz et al61 proposed that the skeletal muscle vasodilation seen during syncope was greater than that caused by sympathetic withdrawal alone. Because cholinergic, nitric oxide, or epinephrine stimulation is not essential, they suggest that still-undiscovered mechanisms are responsible for the vasodilation observed in NMS. In contrast, others have argued that the disappearance of sympathetic vasoconstrictor nerve traffic to the skeletal muscle vascular bed is sufficient to explain vasovagal reactions.34 Overall, more experimental evidence is needed to support the involvement of "active" vasodilation in NMS.
| Respiration |
|---|
|
|
|---|
| Cerebral Blood Flow Dysregulation |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
2. Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope. Eur JCPE. 1992;3:180183.
3.
Fitzpatrick AP, Theodorakis G, Vardas P, et al. The
incidence of malignant vasovagal syndrome in patients with recurrent
syncope. Eur Heart J. 1991;12:389394.
4. Maloney JD, Jaeger FJ, Fouad-Tarazi FM, et al. Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt. Cleve Clin J Med. 1988;55:542548.[Medline] [Order article via Infotrieve]
5. Mosqueda-Garcia R. Central autonomic regulation. In: Robertson D, Low PA, Polinsky R, eds. Primer on the Autonomic Nervous System. San Diego: Academic Press; 1996:311.
6. Kaufmann H. Neurally mediated syncope: pathogenesis, diagnosis, and treatment. Neurology. 1995;45(suppl 5):s12s18.
7. Glick G, Yu PN. Hemodynamic changes during spontaneous vasovagal reactions. Am J Med. 1963;34:4251.[Medline] [Order article via Infotrieve]
8.
Hargreaves AD, Muir AL. Lack of variation in venous
tone potentiates vasovagal syncope. Br Heart J. 1992;67:486490.
9. Mayerson HS, Burch GE. Relationships of tissue (subcutaneous and intramuscular) and venous pressure to syncope induced in man by gravity. Am J Physiol. 1940;128:258265.
10.
Thomson HL, Atherton JJ, Khafagi FA, et al. Failure of
reflex venoconstriction during exercise in patients with vasovagal
syncope. Circulation. 1996;93:953959.
11.
Epstein SE, Stampfer M, Beiser GD. Role of capacitance
and resistance vessels in vasovagal syncope. Circulation. 1968;37:524533.
12. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, et al. Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest. 1997;99:27362744.[Medline] [Order article via Infotrieve]
13. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1:90102.[Abstract]
14. Sharpey-Schafer EP. Emergencies in general practice: syncope. BMJ. 1956;1:506509.
15. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346351.[Abstract]
16. Oberg B, Thoren P. Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat: a possible cause of the vasovagal reaction. Acta Physiol Scand. 1972;85:164173.[Medline] [Order article via Infotrieve]
17.
Morita H, Vatner SF. Effects of hemorrhage on
renal nerve activity in conscious dogs. Circ Res. 1985;57:788793.
18. Scherrer U, Vissing S, Morgan BJ, et al. Vasovagal syncope after infusion of a vasodilator in a heart-transplant patient. N Engl J Med. 1990;322:602604.[Medline] [Order article via Infotrieve]
19. Shaleev Y, Gal R, Tchou PJ. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. J Am Coll Cardiol. 1991;18:746751.[Abstract]
20. Fitzpatrick AP, Williams T, Ahmed R, et al. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur JCPE.. 1992;2:121128.
21. Novak V, Honos G, Schondorf R. Is the heart empty at syncope? J Auton Nerv Syst. 1996;60:8392.[Medline] [Order article via Infotrieve]
22. Lee TM, Chen MF, Su SF, et al. Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head-up tilt. Clin Cardiol. 1996;19:137140.[Medline] [Order article via Infotrieve]
23. Sra JS, Murthy V, Natale A, et al. Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol. 1994;73:3337.[Medline] [Order article via Infotrieve]
24. Goldstein DS, Spanarkel M, Pitterman A, et al. Circulatory control mechanisms in vasodepressor syncope. Am Heart J. 1982;104:10711075.[Medline] [Order article via Infotrieve]
25. Jacobs MC, Goldstein DS, Willemsen JJ, et al. Neurohumoral antecedents of vasodepressor reactions. Eur J Clin Invest. 1995;25:754761.[Medline] [Order article via Infotrieve]
26.
Esler MD, Jennings G, Lambert G, et al. Overflow of
catecholamine neurotransmitters to the circulation: source,
fate and functions. Physiol Rev. 1990;70:963985.
27. Mosqueda-Garcia R. Evaluation of autonomic failure. In: Burnstock G, ed. Disorders of the Autonomic Nervous System. Luxembourg: Harwood Academic Publishers; 1995:2560.
28. Wallin BG, Sundolf G. Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst. 1982;6:287291.[Medline] [Order article via Infotrieve]
29. Smith ML. Mechanisms of vasovagal syncope: relevance to postflight orthostatic intolerance. J Clin Pharmacol. 1994;34:460465.[Abstract]
30. van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal response. Clin Sci.. 1991;81:575586.[Medline] [Order article via Infotrieve]
31. Yatomi A, Iguchi A, Uemura K, et al. A rare case of recurrent vasodepressive attacks of 2-hours duration: analysis of the mechanism by muscle sympathetic nerve activity recording. Clin Cardiol. 1989;12:164168.[Medline] [Order article via Infotrieve]
32. Hayoz D, Noll G, Passino C, et al. Progressive withdrawal of muscle nerve sympathetic activity preceding vasovagal syncope during lower-body negative pressure. Clin Sci. 1996;91(suppl):5051.
33. Mosqueda-Garcia R, Fernandez-Violante R, Snell M, et al. Yohimbine in neurally mediated syncope: pathophysiological implications. J Clin Invest. 1998;102:18241830.[Medline] [Order article via Infotrieve]
34.
Morillo CA, Eckberg DL, Ellenbogen KA, et al. Vagal and
sympathetic mechanisms in patients with orthostatic
vasovagal syncope. Circulation. 1997;96:25092513.
35. Benditt DG, Chen M, Hansen R, et al. Characterization of subcutaneous microvascular blood flow during tilt table-induced neurally mediated syncope. J Am Coll Cardiol. 1995;25:7075.[Abstract]
36. Morillo CA, Klein GJ, Jones DL, et al. Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope. Am J Cardiol. 1994;74:12581262.[Medline] [Order article via Infotrieve]
37.
Furlan R, Piazza S, DellOrto S, et al. Cardiac
autonomic patterns preceding occasional vasovagal reactions in healthy
humans. Circulation. 1998;98:17561761.
38.
Lipsitz LA, Mietus J, Moody GB, et al. Spectral
characteristics of heart rate variability before and during postural
tilt: relations to aging and risk of syncope. Circulation. 1990;81:18031810.
39. Ellenbogen KA, Morillo CA, Wood MA, et al. Neural monitoring of vasovagal syncope. Pacing Clin Electrophysiol. 1997;20:788794.[Medline] [Order article via Infotrieve]
40. Castenfors J, Sjostrand T. Circulatory control via vagal afferents: adjustments of heart rate to variations of blood volume in the rat. Acta Physiol Scand. 1972;84:347354.[Medline] [Order article via Infotrieve]
41. Wahbha MMAE, Morley CA, Al-Shamma YMH, et al. Cardiovascular reflex responses in patients with unexplained syncope. Clin Sci. 1989;77:547553.[Medline] [Order article via Infotrieve]
42. Alder PSJ, France C, Ditto B. Baroreflex sensitivity at rest and during stress in individuals with a history of vasovagal syncope. J Psychosom Res. 1991;35:591597.[Medline] [Order article via Infotrieve]
43. Sneddon JF, Counihan PJ, Bashir Y, et al. Assessment of autonomic function in patients with neurally mediated syncope: cardiopulmonary baroreceptor responses to graded orthostatic stress. J Am Coll Cardiol. 1993;21:11931198.[Abstract]
44.
Thomson HL, Wright K, Frenneaux M. Baroreflex
sensitivity in patients with vasovagal syncope. Circulation. 1997;95:395400.
45.
Victor RG, Thoren P, Morgan DA, et al. Differential
control of adrenal and renal sympathetic nerve activity during
hemorrhagic hypotension in rats. Circ Res. 1989;64:686694.
46. Eckberg DL, Harkins SW, Fritsch JM, et al. Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Inv. 1986;78:366374.
47. Wallin BG, Sundlof G, Delius W. The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch Gesamte Physiol Menschen Tiere. 1975;358:101110.
48. Landgren S. On the excitation mechanism of the carotid baroreceptors. Acta Physiol Scan. 1952;26:134.[Medline] [Order article via Infotrieve]
49. Bergenwald L, Freyschuss U, Sjostrand T. The mechanism of orthostatic and hemorrhagic fainting. Scand J Clin Lab Invest. 1977;37:209216.[Medline] [Order article via Infotrieve]
50.
El-Sayed H, Hainsworth R. Salt supplement increases
plasma volume and orthostatic tolerance in patients with
unexplained syncope. Heart. 1996;75:134140.
51. Scott WA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol. 1995;76:400402.[Medline] [Order article via Infotrieve]
52. Jaeger FJ, Maloney JD, Castle LW, et al. Is absolute hypovolemia a risk factor for vasovagal response to head-up tilt? Pacing Clin Electrophysiol. 1993;16:743750.[Medline] [Order article via Infotrieve]
53. Calkins H, Kadish A, Sousa J, et al. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol. 1991;67:207209.[Medline] [Order article via Infotrieve]
54. Samoil D, Grubb BP. Neurally mediated syncope and serotonin reuptake inhibitors. Clin Auton Res. 1995;5:251255.[Medline] [Order article via Infotrieve]
55.
Morgan DA, Thoren P, Wilczynski EA, et al. Serotonergic
mechanisms mediate renal sympathoinhibition during severe
hemorrhage in rats. Am J Physiol. 1988;255:H496H502.
56. Matzen S, Secher NH, Knigge U, et al. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans. Acta Physiol Scand. 1993;149:163176.[Medline] [Order article via Infotrieve]
57. Riegger GA, Wagner A. Excessive secretion of vasopressin during vasovagal reaction. Am Heart J. 1991;121:602603.[Medline] [Order article via Infotrieve]
58. Perna GP, Ficola U, Salvatori MP, et al. Increase of plasma beta endorphins in vasodepressor syncope. Am J Cardiol. 1990;65:929930.[Medline] [Order article via Infotrieve]
59. Kaufmann H, Oribe E, Oliver JA. Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet. 1991;338:15421545.[Medline] [Order article via Infotrieve]
60. Smith ML, Carlson MD, Thames MD. Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Auton Nerv Syst. 1993;45:19.[Medline] [Order article via Infotrieve]
61.
Dietz NM, Halliwill JR, Spielmann JM, et al.
Sympathetic withdrawal and forearm vasodilation during vasovagal
syncope in humans. J Appl Physiol. 1997;82:17851793.
62. Barcroft H, Edholm OG. On the vasodilation in human skeletal muscle during post-hemorrhagic fainting. J Physiol. 1945;104:161175.
63.
Burke D, Sundlof G, Wallin BG. Postural effects on
muscle nerve sympathetic activity in man. J Physiol. 1977;272:399414.
64. Martin GJ, Adams SL, Martin HG, et al. Prospective evaluation of syncope. Ann Emerg Med. 1984;13:499504.[Medline] [Order article via Infotrieve]
65. Askenasy JJ, Askenasy N. Inhibition of muscle sympathetic activity during yawning. Clin Auton Res. 1996;6:237239.[Medline] [Order article via Infotrieve]
66. Hainsworth R. Fainting. In: Bannister R, ed. Autonomic Failure: a Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford: Oxford University Press; 1988:142.
67.
Lipsitz LA, Morin R, Gagnon M, et al. Vasomotor
instability preceding tilt-induced syncope: does respiration play a
role?. J Appl Physiol. 1997;83:383390.
68. McHenry LC, Fazekas LC, Sullivan JF. Cerebral hemodynamics of syncope. Am J Med Sci. 1961;241:173178.
69. Grubb BP, Gerard G, Roush K, et al. Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. Circulation. 1991;84: 11571164.
This article has been cited by other articles:
![]() |
W. H. Cooke, C. A. Rickards, K. L. Ryan, T. A. Kuusela, and V. A. Convertino Muscle sympathetic nerve activity during intense lower body negative pressure to presyncope in humans J. Physiol., October 15, 2009; 587(20): 4987 - 4999. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sorajja, G. C. Nesbitt, D. O. Hodge, P. A. Low, S. C. Hammill, B. J. Gersh, and W.-K. Shen Syncope While Driving: Clinical Characteristics, Causes, and Prognosis Circulation, September 15, 2009; 120(11): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamiya, T. Kawada, S. Shimizu, S. Iwase, M. Sugimachi, and T. Mano Slow head-up tilt causes lower activation of muscle sympathetic nerve activity: loading speed dependence of orthostatic sympathetic activation in humans Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H53 - H58. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Saadjian, V. Gerolami, R. Giorgi, L. Mercier, J.-L. Berge-Lefranc, F. Paganelli, Z. Ibrahim, Y. By, J. L. Gueant, S. Levy, et al. Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism Eur. Heart J., June 2, 2009; 30(12): 1510 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gill, G. M. Anderson, H. D. Fischer, C. M. Bell, P. Li, S.-L. T. Normand, and P. A. Rochon Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors: A Population-Based Cohort Study Arch Intern Med, May 11, 2009; 169(9): 867 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nollo, L. Faes, R. Antolini, and A. Porta Assessing causality in normal and impaired short-term cardiovascular regulation via nonlinear prediction methods Phil Trans R Soc A, April 13, 2009; 367(1892): 1423 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Porta, G Casucci, S Castoldi, A Rinaldi, and L Bernardi Influence of respiratory instability during neurocardiogenic presyncope on cerebrovascular and cardiovascular dynamics Heart, November 1, 2008; 94(11): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iacoviello, P. Guida, C. Forleo, S. Sorrentino, L. D'Alonzo, and S. Favale Impaired arterial baroreflex function before nitrate-induced vasovagal syncope during head-up tilt test Europace, October 1, 2008; 10(10): 1170 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Taneja, M. S. Medow, J. L. Glover, N. K. Raghunath, and J. M. Stewart Increased vasoconstriction predisposes to hyperpnea and postural faint Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H372 - H381. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Verheyden, H. Ector, A. E. Aubert, and T. Reybrouck Tilt training increases the vasoconstrictor reserve in patients with neurally mediated syncope evoked by head-up tilt testing Eur. Heart J., June 2, 2008; 29(12): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Gupta and M D Nair Neurogenic orthostatic hypotension: chasing "the fall" Postgrad. Med. J., January 1, 2008; 84(987): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Podoleanu, R. Maggi, M. Brignole, F. Croci, A. Incze, A. Solano, E. Puggioni, and E. Carasca Lower Limb and Abdominal Compression Bandages Prevent Progressive Orthostatic Hypotension in Elderly Persons: A Randomized Single-Blind Controlled Study J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schroeder, A. L. Birkenfeld, A. F. Mayer, J. Tank, A. Diedrich, F. C. Luft, and J. Jordan Norepinephrine Transporter Inhibition Prevents Tilt-Induced Pre-Syncope J. Am. Coll. Cardiol., August 1, 2006; 48(3): 516 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Deharo, C. Jego, A. Lanteaume, and P. Djiane An Implantable Loop Recorder Study of Highly Symptomatic Vasovagal Patients: The Heart Rhythm Observed During a Spontaneous Syncope Is Identical to the Recurrent Syncope But Not Correlated With the Head-Up Tilt Test or Adenosine Triphosphate Test J. Am. Coll. Cardiol., February 7, 2006; 47(3): 587 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamiya, T. Kawada, K. Yamamoto, D. Michikami, H. Ariumi, T. Miyamoto, S. Shimizu, K. Uemura, T. Aiba, K. Sunagawa, et al. Dynamic and static baroreflex control of muscle sympathetic nerve activity (SNA) parallels that of renal and cardiac SNA during physiological change in pressure Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2641 - H2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamiya, J. Hayano, T. Kawada, D. Michikami, K. Yamamoto, H. Ariumi, S. Shimizu, K. Uemura, T. Miyamoto, T. Aiba, et al. Low-frequency oscillation of sympathetic nerve activity decreases during development of tilt-induced syncope preceding sympathetic withdrawal and bradycardia Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1758 - H1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Rollinson Understanding and Managing Neurally Mediated Syncope in the Adolescent The Journal of School Nursing, August 1, 2005; 21(4): 200 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamiya, T. Kawada, K. Yamamoto, D. Michikami, H. Ariumi, T. Miyamoto, K. Uemura, M. Sugimachi, and K. Sunagawa Muscle Sympathetic Nerve Activity Averaged Over 1 Minute Parallels Renal and Cardiac Sympathetic Nerve Activity in Response to a Forced Baroreceptor Pressure Change Circulation, July 19, 2005; 112(3): 384 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Grubb Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance Circulation, June 7, 2005; 111(22): 2997 - 3006. [Full Text] [PDF] |
||||
![]() |
B. P. Grubb Neurocardiogenic Syncope N. Engl. J. Med., March 10, 2005; 352(10): 1004 - 1010. [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, K. J. McLeod, S. Sanyal, G. Herzberg, and L. D. Montgomery Relation of Postural Vasovagal Syncope to Splanchnic Hypervolemia in Adolescents Circulation, October 26, 2004; 110(17): 2575 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Furlan, F. Perego, S. Colombo, M. Bechir, C. Binggeli, R. Corti, R. Chenevard, L. Spieker, F. Ruschitzka, T. F. Luscher, et al. Baroreflex Regulation of Sympathetic Nerve Activity in Patients With Vasovagal Syncope * Response Circulation, March 30, 2004; 109(12): e171 - e171. [Full Text] [PDF] |
||||
![]() |
K Deguchi, I Sasaki, T Touge, M Tsukaguchi, H Takeuchi, and S Kuriyama Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 110 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Sapin Autonomic Syncope in Pediatrics: A Practice-Oriented Approach to Classification, Pathophysiology, Diagnosis, and Management Clinical Pediatrics, January 1, 2004; 43(1): 17 - 23. [Abstract] [PDF] |
||||
![]() |
A. Kamiya, D. Michikami, S. Iwase, J. Hayano, T. Kawada, M. Sugimachi, and K. Sunagawa {alpha}-Adrenergic vascular responsiveness to sympathetic nerve activity is intact after head-down bed rest in humans Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R151 - R157. [Abstract] [Full Text] |
||||
![]() |
M. Pitzalis, G. Parati, F. Massari, P. Guida, M. Di Rienzo, B. Rizzon, P. Castiglioni, M. Iacoviello, F. Mastropasqua, and P. Rizzon Enhanced reflex response to baroreceptor deactivation in subjects with tilt-Induced syncope J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schroeder, V. E. Bush, L. J. Norcliffe, F. C. Luft, J. Tank, J. Jordan, and R. Hainsworth Water Drinking Acutely Improves Orthostatic Tolerance in Healthy Subjects Circulation, November 26, 2002; 106(22): 2806 - 2811. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Livolsi, J. Feldman, J. Feingold, L. Weiss, Y. Alembik, I. M. Sharifah-Anion, M. Fischbach, J. Messer, and P. Bousquet First Model of Spontaneous Vagal Hyperreactivity and Its Mode of Genetic Transmission Circulation, October 29, 2002; 106(18): 2301 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, C. Holmes, S. M. Frank, R. Dendi, R. O. Cannon III, Y. Sharabi, M. D. Esler, and G. Eisenhofer Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes Circulation, October 29, 2002; 106(18): 2358 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Moak, J. J. Bailey, and F. T. Makhlouf Simultaneous heart rate and blood pressure variability analysis: Insight into mechanisms underlying neurally mediated cardiac syncope in children J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Flevari, E. G. Livanis, G. N. Theodorakis, E. Zarvalis, T. Mesiskli, and D. T. h Kremastinos Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being J. Am. Coll. Cardiol., August 7, 2002; 40(3): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Saadjian, S. Levy, F. Franceschi, I. Zouher, F. Paganelli, and R. P. Guieu Role of Endogenous Adenosine as a Modulator of Syncope Induced During Tilt Testing Circulation, July 30, 2002; 106(5): 569 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pitzalis, F. Massari, P. Guida, M. Iacoviello, F. Mastropasqua, B. Rizzon, C. Forleo, and P. Rizzon Shortened Head-Up Tilting Test Guided by Systolic Pressure Reductions in Neurocardiogenic Syncope Circulation, January 15, 2002; 105(2): 146 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schondorf, R. Stein, R. Roberts, J. Benoit, and W. Cupples Dynamic cerebral autoregulation is preserved in neurally mediated syncope J Appl Physiol, December 1, 2001; 91(6): 2493 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lagi, S. Cencetti, V. Corsoni, D. Georgiadis, and S. Bacalli Cerebral Vasoconstriction in Vasovagal Syncope: Any Link With Symptoms?: A Transcranial Doppler Study Circulation, November 27, 2001; 104(22): 2694 - 2698. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |